top
Search terms
Results 1 - 10 of 137 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 14
Ehjcvp

Atrial fibrillationIschaemic strokePreventionOral anticoagulationIntroduction Atrial fibrillation (AF) is an expanding epidemic,1 and ischaemic stroke due to cardioembolism remains a trademark ...

European Heart Journal - Cardiovascular Pharmacotherapy, Current Opinion, Thure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y. H. Lip

Date : 01/01/2017 Item size : 256149 bytes
Ehjcvp

Abstract Aims Therapeutic windows for residual platelet reactivity in patients with coronary artery disease on P2Y12 inhibitors were proposed in a consensus document. Conclusions Our results suggest ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Minka J.A. Vries, Heleen J. Bouman, Renske H. Olie, Leo F. Veenstra, Suzanne Zwaveling, Paul W.M. Verhezen, Arina J. ten ...

Date : 01/01/2017 Item size : 286116 bytes
Ehjcvp

[...]authors contemplating submissions of their research in international peer-reviewed journals are now increasingly turning to the EHJCVP. In this comprehensive work, the authors shed light on ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Dan Atar

Date : 01/01/2017 Item size : 171743 bytes
Ehjcvp

[...]they are used widely (almost indiscriminately) in patients with atherosclerotic vascular disease, and in those at risk of disease. AtherosclerosisLipid lowering drugsPlaque imagingIntroduction ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Mohammad Alkhalil, Joshua T. Chai, Robin P. Choudhury

Date : 01/01/2017 Item size : 430492 bytes
Ehjcvp

Abstract Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation (AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin. Using a ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, PÃ¥l Falck, Oddvar Solli, Christian Jonasson

Date : 01/01/2017 Item size : 240628 bytes
Ehjcvp

The HFA Congress hosted the release of the new HFA/ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and these guidelines have been the key theme of the congress.1 ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Giuseppe M.C. Rosano

Date : 01/01/2017 Item size : 111355 bytes
Ehjcvp

In recent years, guidance from both the US Food and Drug Administration (FDA)2 and the European Medicines Agency (EMA)3 addressing evaluation of the cardiovascular risk of new antidiabetic drugs for ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, J. Rick Turner, Dilip R. Karnad, Snehal Kothari, Alan Metz, Hitesh Patel, Erica Caveney

Date : 01/01/2017 Item size : 128050 bytes
Ehjcvp

Abstract The 2016 European Society of Cardiology Heart Failure society as well as the 2016 American Heart Association/American College of Cardiology/Heart Failure Society of America heart failure ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Bertram Pitt, João Pedro Ferreira, Faiez Zannad

Date : 01/01/2017 Item size : 378836 bytes
Ehjcvp

Anticoagulant agents have strong potential to prevent thrombotic events but have a larger risk for serious bleeding complications, as shown in previous clinical trials.4 Antiplatelet agents are ...

European Heart Journal - Cardiovascular Pharmacotherapy, Invited Editorial, Kengo Ayabe, Shinya Goto

Date : 01/01/2017 Item size : 189745 bytes
Ehjcvp

Recently the 2016 version of the European Guidelines on Cardiovascular Disease Prevention has been published by 10 major organizations within the framework of the Sixth Joint Task Force of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Joep Perk

Date : 01/01/2017 Item size : 118151 bytes